Keyphrases
Meta-analysis
100%
Cancer Patients
100%
In Cancer
100%
Carbonic Anhydrase IX
100%
Prognostic Significance
100%
Confidence Interval
85%
Hazard Ratio
85%
High Risk
28%
Tumor Subtype
28%
Solid Tumors
28%
Hypoxia
28%
Prognostic Value
28%
Tumor Site
28%
Tumor
14%
Literature Search
14%
Subgroup Analysis
14%
Treatment Outcome
14%
Overall Survival
14%
Metastasis
14%
PubMed
14%
Embase
14%
Clinical Test
14%
New Treatment Options
14%
Disease Progression
14%
Disease-free Survival
14%
Patients Included
14%
Progression-free Survival
14%
Tumor Cells
14%
Patient Prognosis
14%
Locoregional Control
14%
Adverse Prognostic Factor
14%
Renal Cell Carcinoma
14%
Cellular pH
14%
Regional Failure
14%
Metastasis-free Survival
14%
Control Hazard
14%
Disease-specific Survival
14%
Number of Patients
14%
Risk of Progression
14%
INIS
patients
100%
cancer
100%
carbonic anhydrase
100%
hazards
85%
tumors
71%
diseases
42%
values
28%
risks
28%
hypoxia
28%
metastases
28%
solids
28%
control
14%
kidneys
14%
failures
14%
enzymes
14%
carcinomas
14%
balances
14%
ph value
14%
tumor cells
14%
Medicine and Dentistry
Meta-Analysis
100%
Malignant Neoplasm
100%
Carbonate Dehydratase IX
100%
Hazard Ratio
85%
Neoplasm
42%
Clinical Study
28%
Hypoxia
28%
Solid Malignant Neoplasm
28%
Overall Survival
14%
Prognostic Factor
14%
Progression Free Survival
14%
Metastatic Carcinoma
14%
Tumor Cell
14%
Clear Cell Renal Cell Carcinoma
14%
Subgroup Analysis
14%
Upregulation
14%
Disease Exacerbation
14%
Disease Specific Survival
14%
Disease Free Survival
14%
Metastasis Free Survival
14%
Cell pH
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Carbonate Dehydratase IX
100%
Neoplasm
57%
Clinical Study
28%
Hypoxia
28%
Solid Malignant Neoplasm
28%
Overall Survival
14%
Disease Free Survival
14%
Disease Exacerbation
14%
Progression Free Survival
14%
Disease Specific Survival
14%
Renal Cell Carcinoma
14%
Metastasis Free Survival
14%
Biochemistry, Genetics and Molecular Biology
Carbonic Anhydrase
100%
Clinical Study
28%
Upregulation
14%
Enzyme
14%
Medline
14%
Overall Survival
14%
Embase
14%
Disease Specific Survival
14%
Cell pH
14%
Disease Free Survival
14%
Progression Free Survival
14%
Metastasis Free Survival
14%